Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1371/JOURNAL.PPAT.1007652 | ||||
| Año | 2019 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Enterohemorrhagic Escherichia coli O157:H7 (EHEC) is an important food-borne pathogen that colonizes the colon. Transposon-insertion sequencing (TIS) was used to identify genes required for EHEC and E. coli K-12 growth in vitro and for EHEC growth in vivo in the infant rabbit colon. Surprisingly, many conserved loci contribute to EHEC's but not to K-12' s growth in vitro. There was a restrictive bottleneck for EHEC colonization of the rabbit colon, which complicated identification of EHEC genes facilitating growth in vivo. Both a refined version of an existing analytic framework as well as PCA-based analysis were used to compensate for the effects of the infection bottleneck. These analyses confirmed that the EHEC LEE-encoded type III secretion apparatus is required for growth in vivo and revealed that only a few effectors are critical for in vivo fitness. Over 200 mutants not previously associated with EHEC survival/growth in vivo also appeared attenuated in vivo, and a subset of these putative in vivo fitness factors were validated. Some were found to contribute to efficient type-three secretion while others, including tatABC, oxyR, envC, acrAB, and cvpA, promote EHEC resistance to host-derived stresses. cvpA is also required for intestinal growth of several other enteric pathogens, and proved to be required for EHEC, Vibrio cholerae and Vibrio parahaemolyticus resistance to the bile salt deoxycholate, highlighting the important role of this previously uncharacterized protein in pathogen survival. Collectively, our findings provide a comprehensive framework for understanding EHEC growth in the intestine.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Warr, Alyson R. | Mujer |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos |
| 2 | Hubbard, Troy P. | Hombre |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos |
| 3 | Munera, Diana | Mujer |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos DNA Elect - Reino Unido Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos DNA Electronics - Reino Unido |
| 4 | BLONDEL-BUIJUY, CARLOS JOSE | Hombre |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos Universidad Autónoma de Chile - Chile Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos |
| 5 | zur Wiesch, Pia Abel | Mujer |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos Univ Tromso - Noruega Nord EMBL Partnership - Noruega Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos UiT The Arctic University of Norway - Noruega UiT Norges Arktiske Universitet - Noruega |
| 6 | Abel, Soren | - |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos Univ Tromso - Noruega Nord EMBL Partnership - Noruega Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos Centre for Molecular Medicine Norway - Noruega UiT The Arctic University of Norway - Noruega |
| 7 | Wang, Xiaoxue | - |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos CASSACA - China Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos South China Seas Institute of Oceanography Chinese Academy of Sciences - China South China Sea Institute of Oceanology - China |
| 8 | Davis, Brigid M. | Mujer |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos |
| 9 | Waldor, Matthew K. | Hombre |
Brigham & Womens Hosp - Estados Unidos
Harvard Med Sch - Estados Unidos HHMI - Estados Unidos Brigham and Women's Hospital - Estados Unidos Harvard Medical School - Estados Unidos |
| Fuente |
|---|
| FONDECYT |
| NIH |
| Howard Hughes Medical Institute |
| National Institute of Allergy and Infectious Diseases |
| Research Council of Norway Grant |
| Northern Norway Regional Health Authority Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases |
| Agradecimiento |
|---|
| ARW was funded by grant T32 AI-132120. TPH was funded by grant F31 AI-120665. CJB is an HHMI-Gulbenkian International Research Scholar and was funded by grants FONDECYT 11160901 and REDI170269. PAzW was funded by the Northern Norway Regional Health Authority Grant A67600. SA was funded by the Northern Norway Regional Health Authority Grant SFP1293-16 and Research Council of Norway Grant 249979/RU. MKW was funded by NIH Grants R01 AI-042347 and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |